Abstract:A new binuclear copper (II) complex with 1, 10-phen and fluoroquinolone ligands, [Cu-2(cfc)(2)(phen)(2) (pip)] (NO3)(2)(CO)(2), was synthesized and its crystal structure was solved. The formula of the complex is C28H24ClCuFN5O7, and the crystallography data are as follows, triclinic, space group P (1) over bar, a = 0.80372 (6) nm, b = 0.94712 (7) nm, c = 1.67826(13) nm, alpha = 88.5650(10)degrees, beta = 80.9920(10)degrees, gamma = 70.2780(10)degrees, V = 1.18722(6) nm(3), Z = 2, D = 1.848g . cm(-3), F(000) = 676. R-1 = 0.0627 and omegaR(2) 0.1684 ( I > 2sigma (I)) The copper atom is five-coordinate with square-based pyramidal geometry and involves two nitrogen atoms from phen, two oxygen atoms from cfc and one nitrogen atom from pip anion. The stacking effect between cfc and phen ligands from two neighboring molecules was observed. FT-IR spectrum of the complex was also discussed. Both ligand and complex were assayed against gram-positive and gram-negative bacteria by doubling dilutions method; the complex shows the same minimal inhibitory concentration (MIC) as the corresponding ligand against S. Aureus, E. Coli and M. Lutens bacteria. The inhibitory effect of the ligand and complex on leukemia HL-60 cell line and liver cancer BEL-7402 cell line have been measured by using MTT (Methyl-Thiazol-Tetrozolium) and SRB (Sulphurhodamin B) assay methods, respectively. The results indicated that the complex has strong inhibitory effect on HL-60 and BEL-7402 cell line.

Synthesis, crystal structure, and characterization of mixed-ligand complex of copper(I) with drug of norfloxacin and triphenyl phosphine: [Cu(PPh3)2(H-Norf)]ClO4

Synthesis, Crystal Structure And Antitumor Activity Of Mixed Ligand Coordination Compound Of Copper With Norfloxacin And 1,10-Phen, [Cu(Nflx)(Phen)(H2o)] No3 Center Dot 3h(2)O

Investigation on Ruthenium(II) Bipyridine/AgIII Complexes Chemiluminescence System and Its Application for Sensitive Norfloxacin and Ofloxacin Detection

SYNTHESIS AND CRYSTAL STRUCTURE OF A BINUCLEAR COPPER (II) COMPLEX BRIDGED BY OXAMIDATO, Cu2(μ-CIS-OXPN)(PHEN)(NO3)2

Synthesis, Crystal Structure and Antitumor Activity of Mixed Ligand Coordination Compound of Copper with Norfloxacin and 1, 10-Phen, [Cu(NFLX)(phen)(H2O)] NO3·3H2O

Chlorobis(1,10-phenanthroline-κ2N,N′)copper(II) Nitrate 4-Nitrobenzoic Acid Monohydrate

Synthesis and Crystal Structure of A Binuclear Maleatocopper(Ii) Complex with Phenanthroline

Bis(3-methylbenzoato-κ2O,O′)(phenanthroline-κ2N,N′)copper(II)

Note: Synthesis and Crystal Structure of A Binuclear Fumarate Complexof Copper(II) with 1,10-Phenanthroline

Bis(3‐methylbenzoato‐κ2O,O′)(phenanthroline‐κ2N,N′)copper(II)

2d Nanoporous Molecular Square Grid: Manganese (Ii) Norfloxacin Complex

Two Polymeric Complexes of Norfloxacin with Iron(II) and Their Magnetic Properties

Synthesis, Crystal Structure, Antibacterial And Antitumor Activities Of A New Binuclear Copper(Ii) Complex With 1,10-Phen And Fluoroquinolone

Complexes of Ni(II) and Cu(II) with ofloxacin. Crystal structure of a new Cu(II) ofloxacin complex

Synthesis and structure of a trimeric copper(II) complex of N′-[(1Z)-1H-1,2,4-triazol-3-ylmethylene]-1H-1,2,4-triazole-3- carbohydrazide

Synthesis, Crystal Structure, Antibacterial And Antitumor Activities Of A New Binuclear Copper (Ii) Complex Containing Fluoroquinolone

Synthesis And Crystal Structure Of Fluoroquinolone Complex Of Copper With Two-Dimension Network

Synthesis and Structure of a Trimeric Copper(ii) Complex of N ′-[(1Z)-1h-1,2,4-triazol-3-ylmethylene]- 1 H -1,2,4-Triazole-3-carbohydrazide

Synthesis, Crystal Structures of Novel Complexes of Rare Earth with Norfloxacin, Interaction with DNA and BSA

Crystallographic Report: Bis(norfloxacin)dilead(II) Tetranitrate, [Pb2(h‐norf)2(ono2)4]

2D Molecular Square Grid with Strong Blue Fluorescent Emission: A Complex of Norfloxacin with Zinc(II)